Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30,501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes.
Jing H, Tang Y, Wang ZZ, Wei R, Jin JY, Li J, Zhao LY, Jin J, Liu YP, Song YW, Fang H, Chen B, Qi SN, Lu NN, Tang Y, Li N, Zhai YR, Zhang WW, Wang SL, Li YX. Jing H, et al. Among authors: tang y. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):922-932. doi: 10.1016/j.ijrobp.2022.10.030. Epub 2022 Nov 9. Int J Radiat Oncol Biol Phys. 2023. PMID: 36368434
Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial.
Song YC, Chen SY, Zhao XR, Jing H, Fang H, Tang Y, Hu SY, Song YW, Jin J, Liu YP, Qi SN, Sun GY, Zhong QZ, Du XH, Liu J, Li YX, Wang SL. Song YC, et al. Among authors: tang y. Radiother Oncol. 2024 Oct;199:110390. doi: 10.1016/j.radonc.2024.110390. Epub 2024 Jun 17. Radiother Oncol. 2024. PMID: 38897316 Clinical Trial.
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.
Sun GY, Zhang J, Wang BZ, Jing H, Fang H, Tang Y, Song YW, Jin J, Liu YP, Tang Y, Qi SN, Chen B, Lu NN, Li N, Li YX, Ying JM, Wang SL. Sun GY, et al. Among authors: tang y. Br J Cancer. 2023 Jun;128(11):2044-2053. doi: 10.1038/s41416-023-02218-w. Epub 2023 Mar 25. Br J Cancer. 2023. PMID: 36966236 Free PMC article.
Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018).
Shi Y, Chen H, Qin Y, Yang J, Liu P, He X, Zhou S, Zhou L, Zhang C, Song Y, Liu Y, Gui L, Wang S, Jin J, Fang H, Qi S, Li N, Tang Y, Wang X, Yang S. Shi Y, et al. Among authors: tang y. Cancer Pathog Ther. 2022 Oct 7;1(1):3-11. doi: 10.1016/j.cpt.2022.09.006. eCollection 2023 Jan. Cancer Pathog Ther. 2022. PMID: 38328609 Free PMC article.
Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
Song YC, Kong J, Li N, Liu XL, Li XH, Zhu LY, Wang YW, Fang H, Jing H, Tang Y, Li YX, Wang XH, Zhang J, Wang SL. Song YC, et al. Among authors: tang y. Radiother Oncol. 2023 Jun;183:109639. doi: 10.1016/j.radonc.2023.109639. Epub 2023 Mar 27. Radiother Oncol. 2023. PMID: 36990395
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy.
Wang DQ, Zhang N, Dong LH, Zhong YH, Wu HF, Zhong QZ, Jin J, Hou XR, Jing H, Tang Y, Hu C, Song YW, Liu YP, Qi SN, Tang Y, Lu NN, Chen B, Zhai YR, Zhang WW, Li N, Fang H, Li YX, Wang SL. Wang DQ, et al. Among authors: tang y. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):186-197. doi: 10.1016/j.ijrobp.2023.03.060. Epub 2023 Mar 30. Int J Radiat Oncol Biol Phys. 2023. PMID: 37001764 Free article.
30,501 results
You have reached the last available page of results. Please see the User Guide for more information.